Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Pharmaceuticals & Biotech
/
Aarti Drugs
Create a narrative
Aarti Drugs Community
BSE:524348 Community
1
Narratives
written by author
0
Comments
on narratives written by author
3
Fair Values set
on narratives written by author
Community Investing Ideas
Aarti Drugs
Popular
Undervalued
Overvalued
Aarti Drugs
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
USFDA And MHRA Approvals Will Unlock New Global Markets
Key Takeaways Entry into regulated foreign markets and new capacity expansions will boost exports, revenue growth, and profit margins while leveraging rising global healthcare demand. Backward integration, sustainability initiatives, and China+1 advantages will reinforce cost efficiency, supply stability, and improve competitiveness and ESG standing.
View narrative
₹628.00
FV
23.4% undervalued
intrinsic discount
14.41%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
524348
524348
Aarti Drugs
Your Fair Value
₹
Current Price
₹480.85
5.7% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
47b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹46.7b
Earnings ₹3.6b
Advanced
Set Fair Value